Reported initiation and cessation times for antifungal prophylaxis by patient risk group.
| Patient Group . | Start Date . | End Date . |
|---|---|---|
| * Day of sustained absolute neutrophil count > 0.5 × 109/L | ||
| Abbreviations: Auto HSCT, autologous hematopoietic stem cell transplant; Allo HSCT, allogeneic hematopoietic stem cell transplant. | ||
| Acute leukemia | Day 1 of induction therapy | Myeloid reconstitution* |
| Auto HSCT | Day 1 of conditioning therapy | Myeloid engraftment* |
| Allo HSCT | Day 1 of conditioning therapy Transplant day 0 Transplant day 1 | Myeloid engraftment* Protocol specified day (+75, +100, +120, +180) Cessation of immunosuppressive therapy |
| Patient Group . | Start Date . | End Date . |
|---|---|---|
| * Day of sustained absolute neutrophil count > 0.5 × 109/L | ||
| Abbreviations: Auto HSCT, autologous hematopoietic stem cell transplant; Allo HSCT, allogeneic hematopoietic stem cell transplant. | ||
| Acute leukemia | Day 1 of induction therapy | Myeloid reconstitution* |
| Auto HSCT | Day 1 of conditioning therapy | Myeloid engraftment* |
| Allo HSCT | Day 1 of conditioning therapy Transplant day 0 Transplant day 1 | Myeloid engraftment* Protocol specified day (+75, +100, +120, +180) Cessation of immunosuppressive therapy |